HCAT vs TRUE

Head-to-Head Stock Analysis & Investment Rating

Last Updated: Aug 31, 2026

HCAT

60.8
AI Score
VS
HCAT Wins

TRUE

42.8
AI Score

Investment Advisor Scores

HCAT

Aug 31, 2026
61score
Recommendation
HOLD

TRUE

Aug 31, 2026
43score
Recommendation
HOLD

AI Analyst Insights

Detailed Metrics Comparison

Metric HCAT TRUE Winner
Forward P/E 7.764 14.4509 HCAT
PEG Ratio 0 14.22 Tie
Revenue Growth -12.7% -7.2% TRUE
Earnings Growth 0.0% 0.0% Tie
Tradestie Score 60.8/100 42.8/100 HCAT
Profit Margin -90.6% -10.3% TRUE
Beta 1.00 1.00 Tie
Implied Volatility N/A N/A Tie
AI Recommendation HOLD HOLD Tie

Relative Price Performance (Last 90 Days)

HCAT 1M: -21.5% · 3M: +18.0% TRUE 1M: +14.7% · 3M: +3.7%

Current Technical Phase

HCAT

Neutral
Hold

Mixed signals - no dominant trend phase, RSI 41

RSI (14): 40.7 · Price: $1.64

TRUE

Markup
Hold / add on dips

Price above SMA50, rising 50-day trend (1.0% over 20 days), RSI 70

RSI (14): 69.8 · Price: $2.54

Fundamentals Snapshot

Metric HCAT TRUE
Market Cap
Forward P/E 207.6 -33.0
Trailing P/E
Revenue (TTM)
Revenue Growth -0.1% -0.1%
Gross Margin 0.5% 0.8%
Operating Margin -0.1% -0.2%
EPS -3.68 -0.21
Dividend Yield

Frequently Asked Questions

Based on our detailed analysis, HCAT is currently the stronger investment candidate, winning 2 of the key financial metrics based on our comprehensive scoring model.

We analyze revenue and earnings growth rates in the "Growth" section above. Generally, the company with higher year-over-year revenue and EPS growth is fostering better expansion. Check the table above for the specific growth percentages.

Valuation is determined by metrics like the P/E Ratio and PEG Ratio. A lower P/E typically suggests a stock is cheaper relative to its earnings. Refer to the "Valuation" section in our comparison table to see which stock currently trades at a more attractive multiple.